Skip to content

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06797219
Acronym
EFIL
Enrollment
24
Registered
2025-01-28
Start date
2025-02-25
Completion date
2028-07-31
Last updated
2025-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus, Intraventricular Hemorrhage of Prematurity

Keywords

low level laser therapy, neonate, developmental milestones, intraventricular hemorrhage

Brief summary

The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers' experience with the study intervention. A complete list of objectives and aims are listed under Objectives. This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.

Interventions

DEVICELow Level Laser Therapy for Intraventricular Hemorrhage of Prematurity

The experimental arm will be administered treated with the study device. It will be 10 mW/cm\^2 of 650nm laser through use of a novel laser device given for 5 minutes twice daily for 12 days.

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A device to promote resorption and recovery from intraventricular hemorrhage

Eligibility

Sex/Gender
ALL
Age
0 Days to 1 Months
Healthy volunteers
No

Inclusion criteria

* neonates with intraventricular hemorrhage grade 3 or 4 less than 1 month old.

Exclusion criteria

* neonates without IVH grade 3/4 or older than 1 month.

Design outcomes

Primary

MeasureTime frameDescription
Hemorrhage Resorption RateHemorrhage resorption rate tracking starts from date of identified intraventricular hemorrhage on head ultrasound (usually within 1 week of life) and head ultrasounds weekly up to 4 months oldMeasure rate at which neonate intraventricular hemorrhage is resorbed via serial head ultrasounds
Anterior Horn WidthVentricle volume tracking starts from date of identified intraventricular hemorrhage on head ultrasound (within 1 week of life) performed through weekly head ultrasounds up to 4 months oldMeasure rate at which neonate intracranial pressure changes using anterior horn width (mm) derived from serial head ultrasounds.
Neurosurgical InterventionsNumber of neurosurgical interventions starts at birth and continues up to 4 months oldnumber of patients requiring neurosurgical intervention
Neurodevelopmental Outcomes at 6 months and 12 months of ageTwo time points at 6 months of age and 12 months of ageA phone survey will be conducted inquiring which developmental milestones have been met at 6 months (i.e., sitting independently, reaching to grab toys, knows familiar people, takes turns making sounds with care giver) and 12 months (plays interactive games, says mama/dada, looks for hidden objects, cruises, pincer grasp)
Ventricular IndexVentricle volume tracking starts from date of identified intraventricular hemorrhage on head ultrasound (within 1 week of life); and subsequent weekly head ultrasounds performed up to 4 months oldMeasure rate at which neonate intracranial pressure changes using ventricular index (mm) derived from serial head ultrasounds.
Head CircumferenceHead Circumference tracking starts from birth and is performed daily up to 4 months oldMeasure rate at which neonate intracranial pressure changes via head circumference (cm).

Countries

United States

Contacts

Primary ContactGarrett Gianneschi, Medical
garrettgianneschi@gmail.com908-294-1161
Backup ContactOnajovwe Fofah, Medical
fofahon@njms.rutgers.edu973-972-6753

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026